Related Experiment Videos
Drug-licensing anomalies and Parkinson's disease
Lancet (London, England)
|February 25, 1995
Summary
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Genome-wide approaches to identify pharmacogenetic contributions to adverse drug reactions.
The pharmacogenomics journal·2008
Governance and autonomy in alternatives to hospital care.
Age and ageing·2001
Acute hospital admissions from nursing homes: some may be avoidable.
Postgraduate medical journal·2000
Cognitive impairment associated with beta-blockade in the elderly.
Postgraduate medical journal·1990
Problems of care in a private nursing home.
BMJ (Clinical research ed.)·1990
A survey of private nursing home residents in Weston Super Mare.
Age and ageing·1989
False Friends in Fluorescence - Simple HPLC Evaluation of False Positive Fragment Hits in a DiFMUP Assay for Protein Tyrosine Phosphatase 1B.
Drug design, development and therapy·2026
Rebalancing innovation, affordability, and access for orphan drugs in the European Union.
The Lancet regional health. Europe·2026
Clinical and Economic Burden of Diseases with Accelerated Approval Therapies: Evidence of Unmet Patient Need.
Therapeutic innovation & regulatory science·2026
The Hidden Burden of Parkinson's Disease in Cambodia: A Call to Action.
Public health challenges·2026